Roche app relieves diabetes distress in clinical trial
It is estimated that around 35% of patients with Type 1 and Type 2 diabetes have elevated distress levels, but a digital health application (DiGA)
It is estimated that around 35% of patients with Type 1 and Type 2 diabetes have elevated distress levels, but a digital health application (DiGA)
A new study has found that the onset of Type 2 diabetes is not attributed to having obesity as defined by body mass index (BMI).
Abbott has announced new data from a real-world evidence study in Sweden showing that the use of the FreeStyle Libre continuous glucose monitoring system (CGM)
With the NICE appraisal of who in England and Wales should have access to hybrid closed-loop technology set to conclude by the end of the
Many people with diabetes experience diabetes distress, anxiety, or depression. In turn, depression is linked to chronic conditions like diabetes, high blood pressure, heart disease, arthritis,
People taking semaglutide or liraglutide for weight management are at a higher risk of rare but potentially serious gastrointestinal issues, compared with those taking naltrexone/bupropion,
Diabetes research funding organisation JDRF has announced the appointment of two new Board Directors, Nadia Swann and Sarah Johnson. Johnson is currently Head of Patient
The Royal College of Physicians (RCP) has announced the imminent launch of a programme to improve and standardise diabetes care in hospitals across the UK.
Glooko has launched a sleek new Glooko Mobile App in order to make it easier for users with diabetes to navigate, to organize their data
The National Institute for Health and Clinical Excellence (NICE) has recommended tirzepatide (Mounjaro, produced by Eli Lilly) as a new treatment option for some people